Adjusted OR (95% CI) | P value | Interaction | |
Diabetes (n=73 (543)) | 2.69 (0.72 to 10.14) | 0.14 | |
Not controlled at baseline (n=54 (417)) | 5.35 (0.89 to 32.17) | 0.07 | 0.49 |
Controlled at baseline* (n=15 (109)) | 1.46 (0.06 to 37.26) | 0.82 | |
Hypertension (n=117 (869)) | 3.18 (1.55 to 6.55) | 0.002 | |
Not controlled at baseline (n=48 (364)) | 6.28 (1.79 to 22.06) | 0.004 | 0.29 |
Controlled at baseline† (n=62 (486)) | 2.65 (0.99 to 7.12) | 0.053 |
Individual-level mixed effects analysis adjusting for time and cohort with random intercepts to account for clustering by individual and community (n=number of individual patients (number of time points)). Four patients with diabetes and seven patients with hypertension not included in stratified analysis due to missing baseline control data.
*Defined as glycated haemoglobin (HbA1c) <7%.
†Defined as blood pressure (in mm Hg) <140/90, <130/80 if concomitant diabetes, <150/90 if age ≥80 according to 2010/2014 Mexican Ministry of Health guidelines.17